ESC Premium Access

Do we need PCSK9 inhibitors in post-MI patients? PRO

Congress Presentation

About the speaker

Professor Marc Sabatine

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
25 presentations
1 follower

7 more presentations in this session

Opening question.

Thumbnail

Positioning of the topic - The PCSK9 story .. so far

Speaker: Professor F. Mach (Geneva, CH)

Thumbnail

Do we need PCSK9 inhibitors in post-MI patients? CON

Speaker: Professor H. Drexel (Feldkirch, AT)

Thumbnail

Do we need PCSK9 inhibitors in post-MI patients? Rebuttal PRO

Speaker: Professor M. Sabatine (Boston, US)

Thumbnail

Do we need PCSK9 inhibitors in post-MI patients? Rebuttal CON

Speaker: Professor H. Drexel (Feldkirch, AT)

Thumbnail

Access the full session

Do we need PCSK9 inhibitors in post-MI patients?

Speakers: Professor M. Sabatine, Professor F. Mach, Professor H. Drexel, Professor M. Sabatine, Professor H. Drexel
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb